Related Experiment Video
Updated: Oct 4, 2025
07:20
Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.9K
Treatment options for stage IVA thymic malignancies
1Department of Thoracic Oncology, Institut du Thorax Curie-Montsouris, Institut Curie, Paris, France.
Mediastinum (Hong Kong, China)
|February 4, 2022
Summary
Managing stage IVA thymic epithelial tumors (TETs) involves multidisciplinary collaboration. Treatment options include surgery and systemic agents, especially for locally advanced disease, emphasizing a team-based approach for optimal patient assessment.
Area of Science:
- Oncology
- Thoracic Surgery
- Medical Oncology
Background:
- Thymic malignancies require a multidisciplinary approach for effective management.
- Stage IVA thymic epithelial tumors (TETs) are characterized by intrapleural or intrapericardial spread without distant metastasis.
- These tumors present unique challenges and opportunities for treatment.
Purpose of the Study:
- To review and discuss current management strategies for stage IVA thymic epithelial tumors.
- To highlight the role of multidisciplinary collaboration in treating these rare malignancies.
- To present recently available data on treatment opportunities for advanced thymic tumors.
Main Methods:
- Review of current literature and clinical data on stage IVA thymic epithelial tumors.
- Discussion of surgical treatment options, including intrathoracic delivery.
- Analysis of systemic and combined treatment approaches.
Main Results:
- Multidisciplinary tumor boards are crucial for assessing patients with stage IVA TETs.
- Surgical intervention is a viable option for selected stage IVA cases.
- Systemic agents can be used alone or in combination with local therapies.
Conclusions:
- A multidisciplinary team approach is essential for optimal management of stage IVA thymic epithelial tumors.
- Treatment strategies should be individualized based on tumor characteristics and patient status.
- Further research and data collection are needed to refine treatment protocols for advanced thymic malignancies.
More Related Videos
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
21.6K
11:15Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts
Published on: September 1, 2018
8.1K
Related Concept Videos
01:27Tumor Immunotherapy
711
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
711
02:56Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
02:49Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
01:30Cancer Vaccines
544
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
544
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K